4069-49-2

Basic information

• Product Name: 3',3'''-Methylenebis(2',4',6'-trihydroxy-5'-methylbutyrophenone)
• Synonyms: 1,1'-[Methylenebis(2,4,6-trihydroxy-5-methyl-3,1-phenylene)]bis(1-butanone);3',3'''-Methylenebis(2',4',6'-trihydroxy-5'-methylbutyrophenone);Abbreviatin BB
• CAS NO: 4069-49-2
• Molecular Weight: 0
• Mol File: 4069-49-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3',3'''-Methylenebis(2',4',6'-trihydroxy-5'-methylbutyrophenone)(CAS DataBase Reference)
• NIST Chemistry Reference: 3',3'''-Methylenebis(2',4',6'-trihydroxy-5'-methylbutyrophenone)(4069-49-2)
• EPA Substance Registry System: 3',3'''-Methylenebis(2',4',6'-trihydroxy-5'-methylbutyrophenone)(4069-49-2)

Safety Data

• Hazardous Substances Data: 4069-49-2(Hazardous Substances Data)

Upstream product

• 50-00-0 formaldehyd 
• 1509-06-4 1-[3-methyl-2,4,6-trihydroxyphenyl]-1-butanone 

Relevant articles and documents

Novel diphenylmethyl compounds having mycobacterium tuberculosis inhibitory activity

The invention relates to novel diphenylmethyl derivatives having mycobacterium tuberculosis inhibitory activity and a preparation method thereof and particularly relates novel diphenylmethyl derivatives having activity for inhibiting replicative and non-replicating mycobacterium tuberculosis and a preparation method thereof. In particular, the invention relates to compounds shown in the formula (I) or all possible isomers, prodrugs, pharmaceutically acceptable salts, solvates or hydrates thereof, wherein the variables are as described in the specification. The invention also relates to the preparation method of the compounds and their pharmaceutical compositions and a use of the compounds in preparation of drugs for treating mycobacterium tuberculosis infection-caused diseases.